Nuo Therapeutics, Inc. (AURX)

Cash Conversion Ratio

1.76×

Quarterly · Period ending:

AURX logo

AURX Cash Conversion Ratio

Latest reported1.76×
AURX Quarterly Cash Conversion Ratio (0.11× → 1.76×)
High-resolution chart · PNG

AURX cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. Cash Conversion Ratio — Quarterly
Period endingCash Conversion Ratio
1.7633×
1.2695×
0.8053×
1.3134×
-0.4013×
0.3057×
0.9877×
1.1041×
1.2873×
0.7935×
1.0279×
1.0078×
1.039×
0.9347×
0.8645×
1.1079×
10.625×
-0.0895×
0.367×
0.6642×
1.0497×
0.6754×
0.4671×
0.8155×
0.1503×
1.0225×
0.2587×
0.7576×
0.3327×
1.1416×
-0.1795×
0.5244×
0.0751×
0.2051×
5.6982×
-1.005×
-1.432×
1.0356×
0.4305×
0.7077×
0.7074×
0.1022×
0.7674×
0.808×
1.1766×
0.9743×
0.6032×
0.166×
-0.6647×
0.5033×
1.7292×
0.9133×
0.5959×
0.2907×
0.82×
0.8235×
0.5738×
1.7857×
0.7323×
1.0539×
0.1519×
0.7971×
0.3076×
0.9121×
0.6201×
0.13×
0.8692×
0.6915×
0.7074×
0.6818×
0.4169×
0.5841×
1.0504×
0.5975×
0.524×
0.5844×
0.6459×
0.7483×
0.7454×
0.2891×
0.5851×
0.8551×
0.48×
0.8368×
0.0711×
1.1239×
-0.0614×
0.1846×
0.2012×
0.0512×
0.1556×
0.1837×
0.0587×
0.3241×
0.4742×
0.1139×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.